The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s nasal Polyps treatment market report forecasts the nasal Polyps treatment market size to grow to $6.35 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Nasal Polyps Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report

Nasal Polyps Treatment Market Size Forecast
The global nasal Polyps treatment market is expected to grow from $4.36 billion in 2022 to $4.72 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nasal polyps treatment market size is expected to grow to $6.35 billion in 2027 at a CAGR of 7.7%.

North America held the largest nasal Polyps treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Nasal Polyps Treatment Market Driver ­– Increase In Development Of Novel Approaches For The Treatment Of Nasal Polyps
For instance, in July 2020, GlaxoSmithKline plc (GSK), a UK-based pharmaceutical and biotechnology company, announced that IL-5-targeting monoclonal antibody Nucala (mepolizumab) has been approved by the US Food and Drug Administration (FDA) as a treatment for people with chronic rhinosinusitis with nasal polyps. Adult patients who did not reacted well to nasal corticosteroids used mepolizumab as a maintenance treatment for CRSwNP. Therefore, the development of novel approaches for the treatment of nasal polyps is expected to boost demand for the nasal polyps treatment during the forecast period.

Request for A Sample Of The Global Nasal Polyps Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7109&type=smp

Key Nasal Polyps Treatment Market Trend – New Product Innovation
Major companies operating in the nasal polyps treatment market are focusing on new product innovations to strengthen their position in the market. For instance, in July 2021, GlaxoSmithKline PLC., a UK-based pharmaceutical company, announced the approval for Nucala (mepolizumab) by US Food and Drug Administration (FDA). Nucala (mepolizumab) is a monoclonal antibody that targets interleukin-5 (IL-5) and is a treatment for patients with chronic rhinosinusitis and nasal polyps. This new indication for mepolizumab is for the maintenance treatment of CRSwNP in adult patients aged 18 and up who have not responded to nasal corticosteroids.

Nasal Polyps Treatment Market Segment
1) By Type: Pharmacological Therapies, Surgeries
2) By Route: Oral, Nasal, Other Routes
3) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Nasal Polyps Treatment Market Major Players and Strategies
Major players in the nasal Polyps treatment market are Sanofi S.A., GlaxoSmithKline PLC, F. Hoffmann La Roche AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Novartis International AG, OptiNose US Inc., Regeneron Pharmaceuticals Inc., Intersect ENT Inc., and AstraZeneca PLC.

In September 2021, Merck & Co. Inc., a US-based biopharmaceutical company, acquired Acceleron Pharma Inc. for a deal amount of $11.5 billion. With this acquisition, Acceleron researchers aim to leverage decades of scientific expertise in the biology of the TGF-beta superfamily to create a powerful biotechnology product. Acceleron is a US-based biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases including nasal polyps treatment therapies.

The Nasal Polyps Treatment Global Market Report 2023 covers regional data on nasal Polyps treatment market size, nasal Polyps treatment market trends and drivers, opportunities, strategies, and nasal Polyps treatment market competitor analysis. The countries covered in the nasal Polyps treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Nasal polyps are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses. They dangle like grapes or teardrops and are linked with asthma, persistent infections, allergies, medication sensitivity, and other immunological disorders.

View More Reports Related To The Nasal Polyps Treatment Market –
Nasal Splints Global Market Report 2023
Cough And Cold Preparations Global Market Report 2023
ENT Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: